GlassScriptPhysician profile
Neil J Goldberg
NPI 1184612251
$1,625.95
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $798 · 2020: $177 · 2021: $141 · 2022: $172 · 2023: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $337.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $337.00 | 2023 | |
| Amarin Pharma, INC. | $257.38 | 2019 | |
| Pfizer INC. | $210.09 | 2019 | |
| United Therapeutics Corporation | $177.34 | 2020 | |
| Abbott Laboratories | $157.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $132.08 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $89.38 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.37 | 2019-2021 | |
| Amgen INC. | $41.41 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $34.35 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $32.91 | 2019 | |
| Lilly USA, LLC | $22.77 | 2021 | |
| Sanofi-Aventis U.S. LLC | $21.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.24 | 2021 | |
| Genzyme Corporation | $12.74 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $11.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.